Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing.

about

Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing.

Item

http://www.wikidata.org/entity/Q38432455

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Identification of curcumin-inh ...... A549 cells by RNA sequencing.

@en

type

Item

label

Identification of curcumin-inh ...... A549 cells by RNA sequencing.

@en

prefLabel

Identification of curcumin-inh ...... A549 cells by RNA sequencing.

@en

P1476

Identification of curcumin-inh ...... A549 cells by RNA sequencing.

@en

P2093

Hongfang Zhang

http://www.w3.org/2001/XMLSchema#string

Hongjin Wu

http://www.w3.org/2001/XMLSchema#string

Huiping Li

http://www.w3.org/2001/XMLSchema#string

Qiang Hou

http://www.w3.org/2001/XMLSchema#string

Shixiu Wu

http://www.w3.org/2001/XMLSchema#string

Shuan-Ying Yang

http://www.w3.org/2001/XMLSchema#string

Shuang Li

http://www.w3.org/2001/XMLSchema#string

Ying Li

http://www.w3.org/2001/XMLSchema#string

P2860

Curcumin AntiCancer Studies in Pancreatic Cancer

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients withKRASwild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial

The extracellular matrix: not just pretty fibrils

Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion.

Focal adhesion regulation of cell behavior.

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours

Cell-matrix adhesion.

P304

1010428317705334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1010428317705334

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28618934

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

curcumin